The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
A smooth particle mesh Ewald method
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 22,514
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,317
Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., et al. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21367 · Cited by 7,509
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku340 · Cited by 4,632
Mackerell, A. D., Feig, M., & Brooks, C. L. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20065 · Cited by 3,319
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Motulsky, H. J., & Christopoulos, A. (2004) · Cited by 1,972
Self-citationThe 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Drug-target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2082 · Cited by 1,464
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
GPCR Engineering Yields High-Resolution Structural Insights into β 2 -Adrenergic Receptor Function
Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., et al. (2007) · Science · doi:10.1126/science.1150609 · Cited by 1,336
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., Roth, C. B., Heitman, L. H., IJzerman, A. P., et al. (2012) · Science · doi:10.1126/science.1219218 · Cited by 945
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationAgonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Self-citationStructure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Doré, A. S., Robertson, N., Errey, J. C., Ng, I., Hollenstein, K., Tehan, B., Hurrell, E., Bennett, K., Congreve, M., Magnani, F., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.014 · Cited by 553
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
Massie, B. M., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Weatherley, B. D., Cleland, J. G. F., Givertz, M. M., Voors, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912613 · Cited by 519
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
Bokoch, M. P., Zou, Y., Rasmussen, S. G. F., Liu, C. W., Nygaard, R., Rosenbaum, D. M., Fung, J. J., Choi, H.-J., Thian, F. S., Kobilka, T. S., et al. (2010) · Nature · doi:10.1038/nature08650 · Cited by 470
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Microscale Fluorescent Thermal Stability Assay for Membrane Proteins
Alexandrov, A. I., Mileni, M., Chien, E. Y. T., Hanson, M. A., & Stevens, R. C. (2008) · Structure · doi:10.1016/j.str.2008.02.004 · Cited by 449
Structure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
Recent developments in adenosine receptor ligands and their potential as novel drugs
Müller, C. E., & Jacobson, K. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.017 · Cited by 431
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., et al. (2013) · Nature · doi:10.1038/nature12595 · Cited by 411
Self-citationFlexible protein–ligand docking by global energy optimization in internal coordinates
Totrov, M., & Abagyan, R. (1997) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(1997)1+<215::aid-prot29>3.0.co;2-q · Cited by 407
Docking and scoring with ICM: the benchmarking results and strategies for improvement
Neves, M. A. C., Totrov, M., & Abagyan, R. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9547-0 · Cited by 371
Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Self-citationCrystal structures of the M1 and M4 muscarinic acetylcholine receptors
Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., et al. (2016) · Nature · doi:10.1038/nature17188 · Cited by 335
Self-citationCongreve, M., Andrews, S. P., Doré, A. S., Hollenstein, K., Hurrell, E., Langmead, C. J., Mason, J. S., Ng, I. W., Tehan, B., Zhukov, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201376w · Cited by 305
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
Hino, T., Arakawa, T., Iwanari, H., Yurugi-Kobayashi, T., Ikeda-Suno, C., Nakada-Nakura, Y., Kusano-Arai, O., Weyand, S., Shimamura, T., Nomura, N., et al. (2012) · Nature · doi:10.1038/nature10750 · Cited by 296
Kloner, R. A., Forman, M. B., Gibbons, R. J., Ross, A. M., Alexander, R. W., & Stone, G. W. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl094 · Cited by 253
Mustafa, S. J., Morrison, R. R., Teng, B., & Pelleg, A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_6 · Cited by 251
Foadi, J., Aller, P., Alguel, Y., Cameron, A., Axford, D., Owen, R. L., Armour, W., Waterman, D. G., Iwata, S., & Evans, G. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913012274 · Cited by 250
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
Bruns, R. F., & Fergus, J. H. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09591-4 · Cited by 244
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Leone, R. D., Lo, Y.-C., & Powell, J. D. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.03.008 · Cited by 225
Segala, E., Guo, D., Cheng, R. K. Y., Bortolato, A., Deflorian, F., Doré, A. S., Errey, J. C., Heitman, L. H., IJzerman, A. P., Marshall, F. H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00653 · Cited by 184
Avlani, V. A., Gregory, K. J., Morton, C. J., Parker, M. W., Sexton, P. M., & Christopoulos, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702311200 · Cited by 160
Self-citationAurelio, L., Valant, C., Flynn, B. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002582 · Cited by 134
Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor
Lebon, G., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097360 · Cited by 133
Valant, C., May, L. T., Aurelio, L., Chuo, C. H., White, P. J., Baltos, J., Sexton, P. M., Scammells, P. J., & Christopoulos, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320962111 · Cited by 119
Self-citationSavinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 112
Bruns, R. F., Fergus, J. H., Coughenour, L. L., Courtland, G. G., Pugsley, T. A., Dodd, J. H., & Tinney, F. J. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09597-5 · Cited by 104
van der Klein, P. A. M., Kourounakis, A. P., & IJzerman, A. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991051d · Cited by 93
Tucker, A. L., ROBEVA, A. S., Taylor, H. E., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46872-x · Cited by 87
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design
Jazayeri, A., Dias, J. M., & Marshall, F. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.668251 · Cited by 85
Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
Guo, D. M., Pan, A. C., Dror, R. O., Mocking, T. A. M., Liu, R., Heitman, L. H., Shaw, D. E., & IJzerman, A. P. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.102657 · Cited by 84
Guo, D. M., Heitman, L. H., & IJzerman, A. P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00025 · Cited by 74
Quantification of adenosine A 1 receptor biased agonism: Implications for drug discovery
Baltos, J., Gregory, K. J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L. T. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.013 · Cited by 70
Self-citationPeeters, M. C., Wisse, L. E., Dinaj, A., Vroling, B., Vriend, G., & IJzerman, A. P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.008 · Cited by 66
Allosteric modulation of adenosine receptors
Göblyös, A., & IJzerman, A. P. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.06.013 · Cited by 65
2-Aminothienopyridazines as Novel Adenosine A1Receptor Allosteric Modulators and Antagonists
Ferguson, G. N., Valant, C., Horne, J., Figler, H., Flynn, B. L., Linden, J. M., Chalmers, D. K., Sexton, P. M., Christopoulos, A., & Scammells, P. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800557d · Cited by 59
Self-citationNguyen, A. T. N., Baltos, J., Thomas, T., Nguyen, T. D., Muñoz, L. L., Gregory, K. J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L. T. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105007 · Cited by 55
Self-citationNguyen, A. T. N., Vecchio, E. A., Thomas, T., Nguyen, T. D., Aurelio, L., Scammells, P. J., White, P. J., Sexton, P. M., Gregory, K. J., May, L. T., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105015 · Cited by 51
Self-citationTeerlink, J. R., Iragui, V. J., Mohr, J. P., Carson, P. E., Hauptman, P. J., Lovett, D. H., Miller, A. B., Piña, I. L., Thomson, S. C., Varosy, P. D., et al. (2012) · Drug Safety · doi:10.2165/11594680-000000000-00000 · Cited by 45
Homodimerization of adenosine A1 receptors in brain cortex explains the biphasic effects of caffeine
Gracia, E., Moreno, E., Cortés, A., Lluís, C., Mallol, J., McCormick, P. J., Canela, E. I., & Casadó, V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.005 · Cited by 31
Clinical Efforts to Reduce Myocardial Infarct Size—The Next Step
Braunwald, E. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411407637 · Cited by 25
The Second Extracellular Loop of the Adenosine A1 Receptor Mediates Activity of Allosteric Enhancers
Kennedy, D. P., McRobb, F. M., Leonhardt, S. A., Purdy, M. D., Figler, H., Marshall, M. A., Chordia, M. D., Figler, R. A., Linden, J. M., Abagyan, R. A., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088682 · Cited by 20
Lyons, S. K., Amatangelo, K. L., Behrensmeyer, A. K., Bercovici, A. D., Blois, J. L., Davis, M., DiMichele, W. A., Du, A., Eronen, J. T., Faith, J. T., et al. (2016) · Nature · doi:10.1038/nature19104 · Cited by 16
Cited by
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Gehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Structure of the adenosine-bound human adenosine A1 receptor–Gi complex
Draper-Joyce, C. J., Khoshouei, M., Thal, D. M., Liang, Y.-L., Nguyen, A. T. N., Furness, S. G. B., Venugopal, H., Baltos, J.-A., Plitzko, J. M., Danev, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0236-6 · Cited by 317
Self-citationGPCR activation mechanisms across classes and macro/microscales
Hauser, A. S., Kooistra, A. J., Munk, C., Heydenreich, F. M., Veprintsev, D. B., Bouvier, M., Babu, M. M., & Gloriam, D. E. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00674-7 · Cited by 301
Metadata
- Authors
- Glukhova, A., Thal, D. M., Nguyen, A. T., Vecchio, E. A., Jörg, M., Scammells, P. J., May, L. T., Sexton, P. M., & Christopoulos, A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 168
- Issue
- 5
- Pages
- 867-877.e13
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2594829311
- Cited by
- 275
- References
- 70
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.